Inhaled glycopyrronium bromide: a guide to its use in moderate to severe chronic obstructive pulmonary disease Katherine A. Lyseng-WilliamsonNatalie J. Carter Adis Drug Clinical Q&A 12 October 2013 Pages: 367 - 372
Lomitapide: a guide to its use in adults with homozygous familial hypercholesterolaemia in the EU Katherine A. Lyseng-WillliamsonCaroline M. Perry Adis Drug Clinical Q&A 16 October 2013 Pages: 373 - 378
Ticagrelor: a review of its cost effectiveness in the management of acute coronary syndromes Katherine A. Lyseng-Williamson Adis Pharmacoeconomic Drug Q&A 24 October 2013 Pages: 379 - 386
Early diagnosis and effective drug treatment essential for optimal management of acute viral infections of the CNS Adis Medical Writers Disease Management 15 October 2013 Pages: 387 - 391
Distinguishing ‘adverse drug effects’ from ‘adverse drug reactions’: proposed definitions Adis Medical Writers Practical Issues and Updates 21 August 2013 Pages: 392 - 394
Assess the evidence and prepare plan of action prior to intentional rechallenge with drugs suspected of causing an adverse reaction Adis Medical Writers Practical Issues and Updates 14 September 2013 Pages: 395 - 397
When is the best time for patients with irregular schedules to take agomelatine? Martina HahnMaren LehmannRenate Grohman Case Report 28 September 2013 Pages: 398 - 400